Quarterly report pursuant to Section 13 or 15(d)

Other Income / (Expense)

Other Income / (Expense)

9 Months Ended

Mar. 31, 2023

Note 11. Other Income / (Expense):

The components of other income (expense) in the accompanying Statement of Earnings and Comprehensive Income are as follows (in thousands):


	Quarter Ended				Nine Months Ended
	March 31,				March 31,
	2023		2022		2023		2022
Interest expense	$	(1,367)	$	(2,493)	$	(7,513)	$	(8,804)
Interest income		974		168		2,375		606
Other non-operating income (expense), net⁽¹⁾		378		(19,350)		51,062		14,515
Total other income (expense)	$	(15)	$	(21,675)	$	45,924	$	6,317

⁽¹⁾For the quarter ended March 31, 2023, primarily due to a $0.3 million gain in the fair value of our exchange traded investment grade bond funds compared to a $18.1 million loss in the fair value of our CCXI investment and exchange traded investment grade bond funds in the comparative period. For the nine months ended March 31, 2023, primarily due to a $37.2 million gain on the sale of our CCXI investment and a $11.7 million gain on the sale of Eminence, compared to a $16.5 million gain in the fair value of our CCXI investment in the comparative period.